EC Healthcare (2138.HK)
HKD 0.7
(-1.41%)
HKD 0.7
(-1.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 689.1 Million | 608.32 Million | 603.47 Million | 616.45 Million | 574.37 Million | 238.45 Million |
| Net Income | 16.87 Million | 69.65 Million | 197.5 Million | 192.86 Million | 286.57 Million | 361.1 Million |
| Depreciation & Amortization | 625.54 Million | 586.73 Million | 432.36 Million | 309.86 Million | 245.78 Million | 61.74 Million |
| Deferred income taxes | - | -1.26 Billion | -886.72 Million | -664.5 Million | -469.01 Million | 46.38 Million |
| Stock-based compensation | 11.95 Million | 63.11 Million | 27.68 Million | 9.43 Million | 13.89 Million | 12.54 Million |
| Change in working capital | -47.59 Million | -168.59 Million | -134.77 Million | 80.28 Million | 13.99 Million | -58.92 Million |
| Other non-cash items | 83.43 Million | 1.32 Billion | 967.42 Million | 688.51 Million | 483.14 Million | -184.4 Million |
| Investing Cash Flow | -358.35 Million | -715.62 Million | -586.1 Million | -366.5 Million | 314.9 Million | -17.12 Million |
| Investments in PPE | -161.22 Million | -412.49 Million | -260.26 Million | -149.09 Million | -69.79 Million | -276.21 Million |
| Acquisitions | -210.69 Million | -23.95 Million | -253.93 Million | -319.85 Million | -70.11 Million | 64.73 Million |
| Investment purchases | -40.62 Million | -280.17 Million | -74.65 Million | -6.04 Million | -45.12 Million | -481.77 Million |
| Sales/Maturities of investments | - | 1 Million | 2.75 Million | 108.49 Million | 499.93 Million | 689.08 Million |
| Other Investing Activities | 54.18 Million | -250.65 Million | -23.97 Million | 114.84 Million | 453.38 Million | -12.95 Million |
| Financing Cash Flow | -486.46 Million | -51.31 Million | -80.15 Million | 158.62 Million | -735.81 Million | -148.9 Million |
| Debt repayment | -186.62 Million | -487.99 Million | -287.34 Million | -329.59 Million | -234.21 Million | -1.35 Million |
| Dividends payments | -55.68 Million | -118 Million | -271.95 Million | -113.85 Million | -344.81 Million | -290.21 Million |
| Common Stock Repurchased | - | -367.35 Million | -282.63 Million | -147.9 Million | -163.06 Million | -122.25 Million |
| Common Stock Issuance | - | 8.5 Million | 811.77 Million | 106.84 Million | 2.97 Million | 123.6 Million |
| Other Financing Activities | -119.58 Million | 913.53 Million | -49.98 Million | 643.13 Million | 3.3 Million | -50.52 Million |
| Accounts receivables | -44.78 Million | -36.32 Million | 51.22 Million | -55.27 Million | 32.33 Million | -38.74 Million |
| Accounts payables | -11.53 Million | -14.23 Million | -342 Thousand | -6.75 Million | 9.21 Million | 12.51 Million |
| Inventory | -14.3 Million | 19.97 Million | -45.19 Million | 26.67 Million | -5.1 Million | -20.17 Million |
| Other working capital | 23.03 Million | -138.01 Million | -140.46 Million | 115.62 Million | -22.44 Million | -12.51 Million |
| Cash at beginning of period | 709.85 Million | 870.22 Million | 931.06 Million | 520.44 Million | 366.96 Million | 295.48 Million |
| Cash at end of period | 553.62 Million | 709.85 Million | 870.22 Million | 931.06 Million | 520.44 Million | 366.96 Million |
| Capital Expenditure | -161.22 Million | -412.49 Million | -260.26 Million | -149.09 Million | -69.79 Million | -276.21 Million |
| Effect of forex changes on cash | -516 Thousand | -1.75 Million | 1.94 Million | 2.05 Million | 7992.00 | -926.24 Thousand |
| Net cash flow / Change in cash | -156.23 Million | -160.36 Million | -60.83 Million | 410.62 Million | 153.47 Million | 71.48 Million |
| Free Cash Flow | 527.87 Million | 195.82 Million | 343.2 Million | 467.35 Million | 504.57 Million | -37.76 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -25.59 Million | 16.87 Million | 6.65 Million | 69.65 Million | -10.39 Million | 80.04 Million |
| Depreciation & Amortization | 320.81 Million | 625.54 Million | 304.73 Million | 586.73 Million | 300.67 Million | 286.06 Million |
| Deferred income taxes | - | - | - | -1.26 Billion | -648.11 Million | - |
| Stock-based compensation | 11.95 Million | 11.95 Million | - | 63.11 Million | 63.11 Million | - |
| Change in working capital | 20.07 Million | -47.59 Million | - | -168.59 Million | -94.53 Million | - |
| Other non-cash items | 70.01 Million | 83.43 Million | 589.92 Million | 1.32 Billion | 751.42 Million | 373.98 Million |
| Investing Cash Flow | -143.73 Million | -358.35 Million | -214.62 Million | -715.62 Million | -256.04 Million | -459.58 Million |
| Investments in PPE | -161.22 Million | -161.22 Million | - | -412.49 Million | -411.01 Million | - |
| Acquisitions | -96.01 Million | -210.69 Million | - | -23.95 Million | -62.1 Million | - |
| Investment purchases | - | -40.62 Million | - | -280.17 Million | - | - |
| Sales/Maturities of investments | - | - | - | 1 Million | - | - |
| Other Investing Activities | 113.5 Million | - | -214.62 Million | -250.65 Million | 208.93 Million | -459.58 Million |
| Financing Cash Flow | -330.45 Million | -486.46 Million | -156 Million | -51.31 Million | -187.1 Million | 135.78 Million |
| Debt repayment | - | -186.62 Million | - | -487.99 Million | - | - |
| Dividends payments | -55.68 Million | -55.68 Million | - | -118 Million | -118 Million | - |
| Common Stock Repurchased | - | - | - | -367.35 Million | - | - |
| Common Stock Issuance | - | - | - | 8.5 Million | - | - |
| Other Financing Activities | -274.76 Million | -119.58 Million | -156 Million | 913.53 Million | -57.9 Million | 135.78 Million |
| Accounts receivables | -44.78 Million | -44.78 Million | - | -36.32 Million | -36.32 Million | - |
| Accounts payables | - | -11.53 Million | - | -14.23 Million | - | - |
| Inventory | -14.3 Million | -14.3 Million | - | 19.97 Million | 19.97 Million | - |
| Other working capital | 79.17 Million | 23.03 Million | - | -138.01 Million | -78.19 Million | - |
| Cash at beginning of period | 630.57 Million | 709.85 Million | 709.85 Million | 870.22 Million | 709.53 Million | 870.22 Million |
| Cash at end of period | 553.62 Million | 553.62 Million | 630.57 Million | 709.85 Million | 709.85 Million | 709.53 Million |
| Capital Expenditure | -161.22 Million | -161.22 Million | - | -412.49 Million | -411.01 Million | - |
| Effect of forex changes on cash | -16 Thousand | -516 Thousand | -500 Thousand | -1.75 Million | 3.11 Million | -4.86 Million |
| Net cash flow / Change in cash | -76.94 Million | -156.23 Million | -79.28 Million | -160.36 Million | 324 Thousand | -160.69 Million |
| Free Cash Flow | 236.03 Million | 527.87 Million | 291.84 Million | 195.82 Million | 29.34 Million | 167.96 Million |
NOL
GWRE
TGNO4
0215
SAN
HEKTS